Klaus Hertting
Klaus Hertting has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
Jacobus Reimers
4 shared publicationsKarl-Heinz Kuck
4 shared publicationsKorff Krause
3 shared publications- Tobias Härle
Klinikum Oldenburg, European Medical School, Carl von Ossietzky University, Oldenburg, Germany
3 shared publications Sigrid Boczor
2 shared publications- Werner Raut
Department of Cardiology and Angiology, Krankenhaus Buchholz, 21244 Buchholz in der Nordheide, Germany
1 shared publication
Latest Publications
- Open Access
- 26 August 2015
- Published by Hindawi Limited in Case Reports in Vascular Medicine
- Vol. 2015, 1-4
Successful Use of the MYNXGRIP Closure Device during Repeated Transbrachial Percutaneous Peripheral Intervention
The use of closure devices after transbrachial arterial puncture is still controversial. Here we report on a case where the MYNXGRIP (AccessClosure Inc., Santa Clara, CA, USA) could be used successfully in a patient, who underwent percutaneous peripheral arterial intervention twice via transbrachial access. The use of closure devices after transbrachial arterial puncture is still controversial. Here we report on a case where the MYNXGRIP (AccessClosure Inc., Santa Clara, CA, USA) could be used successfully in a patient, who underwent percutaneous peripheral arterial intervention twice via transbrachial access.
- 26 August 2015
- Published by Hindawi Limited in Case Reports in Vascular Medicine
- Vol. 2015, 1-4
Open AccessSuccessful Use of the MYNXGRIP Closure Device during Repeated Transbrachial Percutaneous Peripheral Intervention
The use of closure devices after transbrachial arterial puncture is still controversial. Here we report on a case where the MYNXGRIP (AccessClosure Inc., Santa Clara, CA, USA) could be used successfully in a patient, who underwent percutaneous peripheral arterial intervention twice via transbrachial access. The use of closure devices after transbrachial arterial puncture is still controversial. Here we report on a case where the MYNXGRIP (AccessClosure Inc., Santa Clara, CA, USA) could be used successfully in a patient, who underwent percutaneous peripheral arterial intervention twice via transbrachial access.
- 1 January 2008
- Vol. 13 (1) , 37-41
Stenting of unprotected left main stem stenosis: Results from a German single-centre registry.
To elucidate the influence of drug-eluting stents (DESs) on interventional therapy of de novo unprotected left main stem (LMS) lesions in a hospital with on-site cardiac surgery. A retrospective study of all patients with unprotected LMS angioplasty from 1999 to 2005 was conducted with regard to clinical and procedural data, and follow-up data. Fifty-four patients with unprotected LMS stenosis were treated inter-ventionally. Of these patients, 16 were treated with DESs. Seven patients presented with cardiogenic shock. During their hospital stay, four patients died (all treated with bare metal stents [BMSs], three initially presenting with cardiogenic shock). Follow-up data for 53 patients (98%) were obtained. Median follow-up time was 24 months (25th percentile, 12 months; 75th percentile, 35 months). Survival after nine months was 87% (81% from the BMS-treated group, and 100% from the DES-treated group). Control angiography had been performed in 36 patients (67%). Patients with unprotected LMS with an angiographic follow-up had a higher nine-month survival rate than patients without (36 of 36 patients [100%] versus 10 of 17 patients [59%], respectively; P<0.0001). Target lesion revascularization rate was 19% in both the BMS and the DES groups. Methods of revascularization did not vary significantly between the groups. In the present study of selected patients with LMS stenosis, the use of DESs showed a low mortality rate but did not have a clear effect on target lesion revascularization rate compared with BMSs. A close follow-up appears to be mandatory to achieve acceptable results.
- 1 January 2008
- Vol. 13 (1) , 37-41
Stenting of unprotected left main stem stenosis: Results from a German single-centre registry.
To elucidate the influence of drug-eluting stents (DESs) on interventional therapy of de novo unprotected left main stem (LMS) lesions in a hospital with on-site cardiac surgery. A retrospective study of all patients with unprotected LMS angioplasty from 1999 to 2005 was conducted with regard to clinical and procedural data, and follow-up data. Fifty-four patients with unprotected LMS stenosis were treated inter-ventionally. Of these patients, 16 were treated with DESs. Seven patients presented with cardiogenic shock. During their hospital stay, four patients died (all treated with bare metal stents [BMSs], three initially presenting with cardiogenic shock). Follow-up data for 53 patients (98%) were obtained. Median follow-up time was 24 months (25th percentile, 12 months; 75th percentile, 35 months). Survival after nine months was 87% (81% from the BMS-treated group, and 100% from the DES-treated group). Control angiography had been performed in 36 patients (67%). Patients with unprotected LMS with an angiographic follow-up had a higher nine-month survival rate than patients without (36 of 36 patients [100%] versus 10 of 17 patients [59%], respectively; P<0.0001). Target lesion revascularization rate was 19% in both the BMS and the DES groups. Methods of revascularization did not vary significantly between the groups. In the present study of selected patients with LMS stenosis, the use of DESs showed a low mortality rate but did not have a clear effect on target lesion revascularization rate compared with BMSs. A close follow-up appears to be mandatory to achieve acceptable results.
- 27 June 2007
- Published by Springer Nature in Clinical Research in Cardiology
- Vol. 96 (8) , 579-581
A 21-year-old male with reduced left ventricular function
- 27 June 2007
- Published by Springer Nature in Clinical Research in Cardiology
- Vol. 96 (8) , 579-581
A 21-year-old male with reduced left ventricular function
- 1 February 2007
- Published by Wiley in Journal of Interventional Cardiology
- Vol. 20 (1) , 51-53
Aneurysm of the Left Main Stem Leading to Anterior Wall Infarction
We report a case of a woman with a spontaneous dissection of the left main stem leading to a large aneurysm compressing the left coronary artery. The lesion was initially treated with a conventional multicellular stent. However, persistence of the aneurysm required that two polytetrafluoroethylene-covered stents be implanted. Follow-up angiographic and clinical results were excellent.
- 1 February 2007
- Published by Wiley in Journal of Interventional Cardiology
- Vol. 20 (1) , 51-53
Aneurysm of the Left Main Stem Leading to Anterior Wall Infarction
We report a case of a woman with a spontaneous dissection of the left main stem leading to a large aneurysm compressing the left coronary artery. The lesion was initially treated with a conventional multicellular stent. However, persistence of the aneurysm required that two polytetrafluoroethylene-covered stents be implanted. Follow-up angiographic and clinical results were excellent.
- 1 October 2006
- Published by Elsevier in International Journal of Cardiology
- Vol. 112 (3) , 282-288
Transient left ventricular apical ballooning in a community hospital in Germany
- 1 October 2006
- Published by Elsevier in International Journal of Cardiology
- Vol. 112 (3) , 282-288
Transient left ventricular apical ballooning in a community hospital in Germany